Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Solgar Zinc Citrate 30mg capsules
090504100BBFTA0
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | 4 |
|
Bio-Selenium+Zinc tablets
090504100BBDHA0
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | 1 |
|
Solgar Zinc 50 tablets
090504100BBFDA0
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | 1 |
|
Boots Vitamin C and Zinc tablets
090504100BBIJA0
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
G & G Zinc citrate 15mg capsules
090504100BBITBD
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
G & G Zinc citrate 50mg capsules
090504100BBISBB
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Lamberts Zinc 15mg tablets
090504100BBBQBC
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Lamberts Zinc 50mg capsules
090504100BBBRBB
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Lloydspharmacy Zinc 15mg tablets
090504100BBIRBA
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Solgar Chelated Zinc 22mg tablets
090504100BBFVA0
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.